Title
Cell-Mediated Biointerfacial Phenolic Assembly for Probiotic Nano Encapsulation
Date Issued
01 June 2022
Access level
open access
Resource Type
journal article
Author(s)
Merhebi S.
Baharfar M.
Abbasi R.
Zhang C.
Mousavi M.
Xie W.
Yang J.
Cao Z.
Allioux F.M.
Harm G.F.S.
Biazik J.
Kalantar-Zadeh K.
Rahim M.A.
University of New South Wales
Publisher(s)
John Wiley and Sons Inc
Abstract
The use of cell-mediated chemistry is an emerging strategy that exploits the metabolic processes of living cells to develop biomimetic materials with advanced functionalities and enhanced biocompatibility. Here, a concept of a cell-mediated catalytic process for forming protective nano-shells on individual probiotic cells is demonstrated. This process is leveraged by the cell environment to induce oxidative polymerization of phenolic compounds, and simultaneously these phenolic polymers assemble to form nano-coatings around individual cell surfaces. The detailed analysis reveals that the oxidation process is triggered by an essential nutrient (manganese) of the probiotic cells, which significantly increases the oxidation rate of phenolic compounds. The phenolic coatings, encapsulating each cell in nanometre scale, demonstrate excellent biocompatibility and biodegradability. Additionally, the in situ encapsulated probiotic cells display an improved gastric tolerance of up to ≈1.4 times higher than the native cells and enhanced adhesion as high as ≈1.6 times onto a model of intestinal epithelial cells. Finally, the coated probiotic cells exhibit a high antioxidant activity as an advanced feature. Overall, this method provides a unique approach to improve the probiotic delivery using the cell machinery to engineer encapsulating nanocoatings with protective benefits and new functionalities.
Volume
32
Issue
26
Language
English
OCDE Knowledge area
Ingeniería química
Scopus EID
2-s2.0-85126740577
Source
Advanced Functional Materials
ISSN of the container
1616301X
Sponsor(s)
The authors thank Mr. Shaun Roux from Probiotics Australia Pty Ltd for the generous supply of probiotic cells, and Dr. Irene Moroni for the generous supply of the Caco-2 human colon adenocarcinoma cell line. In addition, the authors acknowledge the facilities, and the scientific and technical assistance of the Australian Microscopy & Microanalysis Research Facility at the Electron Microscope Unit, The University of New South Wales. The authors would like to acknowledge the NHMRC Development Grant No. APP1154969 for the financial coverage of this study. M.A.R. also acknowledges the ARC Discovery Early Career Researcher Award (DECRA) (Grant No. DE210101162). Open access publishing facilitated by University of New South Wales, as part of the Wiley - University of New South Wales agreement via the Council of Australian University Librarians. The authors thank Mr. Shaun Roux from Probiotics Australia Pty Ltd for the generous supply of probiotic cells, and Dr. Irene Moroni for the generous supply of the Caco‐2 human colon adenocarcinoma cell line. In addition, the authors acknowledge the facilities, and the scientific and technical assistance of the Australian Microscopy & Microanalysis Research Facility at the Electron Microscope Unit, The University of New South Wales. The authors would like to acknowledge the NHMRC Development Grant No. APP1154969 for the financial coverage of this study. M.A.R. also acknowledges the ARC Discovery Early Career Researcher Award (DECRA) (Grant No. DE210101162).
Sources of information: Directorio de Producción Científica Scopus